Glanbia plc (GL9) Fair Value & Analysis
Consumer Defensive · IE · Market cap €5.2B
Fair value as of: Jun 24, 2026
From 25 valuation models · updated 6 days ago
Fair value updated Jun 24, 2026 — revised from €13.92 to €15.93 (+14.4%) since Jun 23, 2026. Share price +2.9% over the past month.
Price vs Fair Value (12 months)
12‑month range €12.10 – €22.60 · fair‑value band €11.52 – €19.91 · the €21.34 price screens above the €15.93 fair value. As of Jun 24, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
Glanbia plc (GL9) currently trades at €21.34, while our model-based Fair Value estimate is €15.93 — implying the stock looks roughly 25.4% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Glanbia plc generated revenue of €3.9B at a net margin of 4.7%. Revenue declined 0.2% year over year. It earns a return on equity of 9.2%. Net debt stands at €526M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Glanbia plc reported revenue of €3.9B in FY2025 versus €4.2B in FY2021, a compound −1.5%/yr. Reported net income was €183M in FY2025, compounding +2.4%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NSRGF | $97.58 | $65.41 | -33% |
| Foshan Haitian Flavouring and Food Company 603288 | ¥35.10 | ¥25.34 | -28% |
| Nestlé India Limited NESTLEIND | ₹1,386 | ₹278.10 | -80% |
| Grupo Bimbo, S.A. BIMBOA | 57.10 MXN | 72.19 MXN | +26% |
| Uni-President Enterprises Corp 1216 | 75.60 TWD | 55.53 TWD | -27% |
| Britannia Industries Limited BRITANNIA | ₹5,171 | ₹1,966 | -62% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Glanbia plc (GL9) undervalued?
What is the fair value of GL9?
What is the quality score of GL9?
What is the revenue of Glanbia plc (GL9)?
What is the net profit margin of GL9?
Does Glanbia plc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.